Aureon to Team with MD Anderson on Lung Cancer Biomarker Study | GenomeWeb
NEW YORK (GenomeWeb News) – Aureon Laboratories will work with MD Anderson Cancer Center to search for biomarkers associated with non-small cell lung cancer patients, the Yonkers, NY-based company said on Monday.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.